Canada Markets closed

Biomerica, Inc. (BMRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.1500+0.0900 (+2.94%)
At close: 04:00PM EDT
3.2200 +0.07 (+2.22%)
After hours: 05:07PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.0600
Bid2.9100 x 3000
Ask3.1600 x 1200
Day's Range2.9801 - 3.2100
52 Week Range2.6500 - 7.3800
Avg. Volume38,860
Market Cap39.407M
Beta (5Y Monthly)-0.68
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A

    36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

    RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th \- 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The Spring into Action: VIRTUAL begins on Monday, May 16th, 2022, with a Biotech Discovery Day.

  • GlobeNewswire

    Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™

    - Attaining CE Mark is a major step toward commercialization – - World Health Organization (WHO) lists H. pylori among the 16 antibiotic-resistant bacteria that pose the greatest threat to human health and designated H. pylori as a Class 1 carcinogen, meaning that it is a known cause of cancer - - 45% of the population in Europe’s five largest countries are afflicted with H. pylori - IRVINE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provide

  • GlobeNewswire

    Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

    Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric cancers are attributed to H. pylori bacterial infection H. pylori infection is also a major cause of peptic ulcers IRVINE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products, today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administratio